Academic programme. a. The International Master in Innovative Medicine is a two-year international master programme focusing on the education of translational biomedical researchers. The IMIM mission is to educate the future generation of leading translational scientists and professionals who will have the skills and competences to work effectively in different multi-/interdisciplinary and internationally competitive academic and private sector environments. b. IMIM’s integrated curriculum is primarily based on and draws from four already accredited English-taught and International Master programmes taught at each of the European Partner Institutions. Each of these four existing degree programmes is small-scale and selective in nature. The four programmes are the two- year Master programme in Medical and Pharmaceutical Drug Innovation at the Rijksuniversiteit Groningen, the one-year Master programme in Translational Medical Research at ▇▇▇▇▇▇▇▇-▇▇▇▇▇-Universität Heidelberg, and the two-year Master programmes in Molecular Medicine and Medical Research at Uppsala Universitet. c. As well as taking courses drawn from the four participating master programmes, IMIM students will also have the opportunity to engage in research internships, their own research project, and, if they choose and are accepted by the relevant Partner Institution, a semester abroad in one of the Latin American Partner Institutions, as well as being obliged to take part in IMIM’s “learning line” activities under the “Bench to Bedside and Back” (BBB) scheme as detailed below: d. The EMJMD IMIM will be offered as a Double Degree programme. In certain cases a multiple (i.c. triple) degree may be awarded providing the applicable requirements have been met. e. The academic programme, the learning outcomes, the mandatory modules and the mobility paths facilitated by the Consortium, the Partner Institutions and Associated Partners as part of this Degree Programme will be established in the “Study, Teaching and Exam Regulations” annexed to this Agreement. f. Although the semester timetables may differ slightly in each Partner Institution, every effort is made to ensure that students attending the Degree Programme at different locations will start and finish in the same time period allowing adequate transition time between mobility periods. Care will also be taken to ensure a balanced workload for students at each location. g. The Partner Institutions will be responsible for the delivery of their own modules while taking into account joint agreements on learning outcomes, teaching and assessment methods, literature, textbooks and other learning materials. h. The Management Committee will be responsible for jointly developing and continually evaluating and improving the Degree Programme and its modules, taking into account the recommendations of the Programme Committee. i. Changes and variations to the structure and content of the Degree Programme as outlined in the Study, Teaching and Exam Regulations may only be implemented within the limits specified by the Management Committee and following approval of the Management Committee. However, changes and variations to the structure and content of the existing local master programmes will be approved by the local University, but in consideration to IMIM , and they will inform the Management Committee of these developments.
Appears in 2 contracts
Sources: Consortium Agreement, Consortium Agreement